Cargando…
Treatment of HIV-related primary central nervous system lymphoma with azt high dose, HAART, interleukin-2 and foscarnet in three patients
PURPOSE: Combined immunomodulatory and antiviral treatment was administered to three patients with newly diagnosed HIV-associated primary central nervous system lymphoma (PCNSL) in an attempt to improve outcomes. PATIENTS AND METHODS: Three patients from our institution who were recently diagnosed w...
Autores principales: | Marretta, L, Stocker, H, Drauz, D, Mueller, M, Masuhr, A, Dieckmann, S, Wong, V, Koch, A, Grueneisen, A, Arastéh, K, Weiss, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352191/ https://www.ncbi.nlm.nih.gov/pubmed/21719392 http://dx.doi.org/10.1186/2047-783X-16-5-197 |
Ejemplares similares
-
Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing
por: Gaduputi, Vinaya, et al.
Publicado: (2013) -
AZT as a telomerase inhibitor
por: Gomez, Daniel E., et al.
Publicado: (2012) -
Foscarnet-induced genital lesions: An overview with a case report
por: Adalsteinsson, Jonas A., et al.
Publicado: (2018) -
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
por: Hakki, Morgan
Publicado: (2020) -
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)